Business Description
Kindstar Globalgene Technology Inc
ISIN : KYG5262E1044
Total Employee Number:
3,100Compare
Compare
Traded in other countries / regions
09960.Hong Kong IPO Date
2021-07-16Description
Kindstar Globalgene Technology Inc is engaged in the provision of clinical testing services in China. It operates in nine segments: Hematology testing segment includes testing services related to blood diseases; Genetic diseases and rare diseases segment includes testing services for rare diseases; Infectious diseases segment includes testing services from the infection department; Oncology segment includes testing related to oncology diseases; Neurology segment includes testing services related to neurological diseases undertaken by the Group; Maternity-related diseases segment includes testing services related to maternity; Routine testing segment conducts routine tests for the doctors daily diagnoses; CROs & R&D project segment includes research & develop services; & others segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.74 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | 5.19 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.21 | |||||
Beneish M-Score | -2.77 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -18.1 | |||||
3-Year EBITDA Growth Rate | -24.4 | |||||
3-Year Book Growth Rate | -4.7 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 70.82 | |||||
9-Day RSI | 60.21 | |||||
14-Day RSI | 54.9 | |||||
3-1 Month Momentum % | -13.33 | |||||
6-1 Month Momentum % | -24.17 | |||||
12-1 Month Momentum % | -38.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.81 | |||||
Quick Ratio | 2.74 | |||||
Cash Ratio | 2.1 | |||||
Days Inventory | 38.08 | |||||
Days Sales Outstanding | 232.35 | |||||
Days Payable | 110.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 9.5 | |||||
Forward Dividend Yield % | 9.5 | |||||
5-Year Yield-on-Cost % | 9.5 | |||||
3-Year Average Share Buyback Ratio | -3.4 | |||||
Shareholder Yield % | 2.06 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 44.02 | |||||
Operating Margin % | -8.88 | |||||
Net Margin % | -6.28 | |||||
EBITDA Margin % | 8.58 | |||||
FCF Margin % | 4.76 | |||||
OCF Margin % | 9.86 | |||||
ROE % | -2.14 | |||||
ROA % | -1.55 | |||||
ROIC % | -4.11 | |||||
3-Year ROIIC % | -22.09 | |||||
ROC (Joel Greenblatt) % | -3.53 | |||||
ROCE % | -0.85 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 10.53 | |||||
PS Ratio | 0.97 | |||||
PB Ratio | 0.34 | |||||
Price-to-Tangible-Book | 0.38 | |||||
Price-to-Free-Cash-Flow | 23.25 | |||||
Price-to-Operating-Cash-Flow | 10.53 | |||||
EV-to-EBIT | 8.08 | |||||
EV-to-Forward-EBIT | 0.6 | |||||
EV-to-EBITDA | -2.56 | |||||
EV-to-Forward-EBITDA | 0.18 | |||||
EV-to-Revenue | -0.22 | |||||
EV-to-Forward-Revenue | 0.02 | |||||
EV-to-FCF | -4.61 | |||||
Price-to-GF-Value | 0.94 | |||||
Price-to-Projected-FCF | 0.63 | |||||
| Price-to-Net-Current-Asset-Value | 0.89 | |||||
| Price-to-Net-Cash | 1.79 | |||||
Earnings Yield (Greenblatt) % | 12.38 | |||||
FCF Yield % | 4.73 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kindstar Globalgene Technology Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 1,026.002 | ||
| EPS (TTM) (HK$) | -0.065 | ||
| Beta | 0.7452 | ||
| 3-Year Sharpe Ratio | -0.74 | ||
| 3-Year Sortino Ratio | -0.93 | ||
| Volatility % | 18.24 | ||
| 14-Day RSI | 54.9 | ||
| 14-Day ATR (HK$) | 0.036984 | ||
| 20-Day SMA (HK$) | 0.9455 | ||
| 12-1 Month Momentum % | -38.51 | ||
| 52-Week Range (HK$) | 0.905 - 1.56 | ||
| Shares Outstanding (Mil) | 1,033.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kindstar Globalgene Technology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kindstar Globalgene Technology Inc Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| HKD 0.095000 Cash Dividend | 2026-06-09 | 1.05 (+1.94%) | ||
| HKD 0.023800 Cash Dividend | 2025-06-09 | 1.29 (+1.57%) |
Show
Entries
Kindstar Globalgene Technology Inc Frequently Asked Questions
What is Kindstar Globalgene Technology Inc(HKSE:09960)'s stock price today?
The current price of HKSE:09960 is HK$1.00. The 52 week high of HKSE:09960 is HK$1.56 and 52 week low is HK$0.91.
When is next earnings date of Kindstar Globalgene Technology Inc(HKSE:09960)?
The next earnings date of Kindstar Globalgene Technology Inc(HKSE:09960) is .
Does Kindstar Globalgene Technology Inc(HKSE:09960) pay dividends? If so, how much?
The Dividend Yield %  of Kindstar Globalgene Technology Inc(HKSE:09960) is 9.5% (As of Today), Highest Dividend Payout Ratio of Kindstar Globalgene Technology Inc(HKSE:09960) was 1.75. The lowest was 1.75. And the median was 1.75. The  Forward Dividend Yield % of Kindstar Globalgene Technology Inc(HKSE:09960) is 9.5%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Kindstar Globalgene Technology Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers